Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents

Details for Australian Patent Application No. 2008321128 (hide)

Owner BIPAR SCIENCES, INC.

Inventors Ossovskaya, Valeria S.; Sherman, Barry; Bradley, Charles

Agent A J Park

Pub. Number AU-A-2008321128

PCT Pub. Number WO2009/064738

Priority 60/987,333 12.11.07 US; 61/058,528 03.06.08 US; 61/012,364 07.12.07 US

Filing date 11 November 2008

Wipo publication date 22 May 2009

International Classifications

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 July 2010 PCT application entered the National Phase

  PCT publication WO2009/064738 Priority application(s): WO2009/064738

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321129-Encapsulated low viscosity hydrophobic liquid actives

2008321109-Imidazoline-based heterocyclic foamers for downhole injection